Hyperdifferentiated murine melanoma cells promote adaptive anti-tumor immunity but activate the immune checkpoint system

Hyperdifferentiated murine melanoma cells promote adaptive anti-tumor immunity but activate the immune checkpoint system

Accumulating evidence suggests that phenotype switching of cancer cells is essential for therapeutic resistance. However, the immunological characteristics of drug-induced phenotype-switching melanoma cells (PSMCs) are unknown. We investigated PSMC elimination by host immunity using hyperdifferentia...

Full description

Bibliographic Details
Main Authors: Yukie Ando, Yutaka Horiuchi, Sara Hatazawa, Momo Mataki, Akihiro Nakamura, Takashi Murakami
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:OncoImmunology
Subjects:
Anti-tumor immunity
immune checkpoint inhibitors
malignant melanoma
phenotype switching
Online Access:https://www.tandfonline.com/doi/10.1080/2162402X.2024.2437211

Internet

https://www.tandfonline.com/doi/10.1080/2162402X.2024.2437211

Similar Items